Oral administration of Lupeol to dextran sulfate sodium (DSS)-induced colitis mice reduced intestinal inflammation and increased survival. This was associated with decreased expression of M1-related genes and increased expression of M2-related genes. Lupeol ameliorates experimental inflammatory bowel disease, at least in part, through inhibiting M1 and promoting M2 macrophages [2
]. Similar results were simultaneously published in a different journal [1
]. Note there are many isomers of this structure that can be found using the "same connectivity" operator in the PubChem CID entry.